Virnich Daniel
- SEC CIK
- 0001891107
No open-market purchases or sales filed in the past year.
Current role at each company
- DFPH Starling Oncology, Inc.Chief Executive Officeras of May 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Virnich Daniel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2025 (view filing)5:50 PM ET | Mar 26 | 2 days | Virnich DanielChief Executive Officer | PPurchase | +22.6K | $1.04 | +$23.6K | +3.2%724.4K after | |
| Mar 28, 2025 (view filing)5:50 PM ET | Mar 26 | 2 days | Virnich DanielChief Executive Officer | PPurchase | +11.3K | $0.125 | +$1.42K | –11.3K after | Derivative |
| Nov 22, 2022 (view filing) | Nov 15 | 7 days | Virnich DanielPresident | SSale | −3.77K | $2.03 | −$7.65K | −1.6%233.5K after | Amended |